Additionally, it may help reduce the risk of heart attacks by adjusting the blood flow in the arteries and preventing blood from clotting
Similarly, SGLT2 inhibitors have demonstrated robust cardiovascular and renal benefits, including reductions in cardiovascular events and all-cause mortality, with consistent effects across the drug class and irrespective of diabetes status [6, 7] Their metabolic benefitssuch as weight loss, improved lipid profiles, and reduced visceral adipositycontribute to a favourable cardiovascular risk profile, countering the pro-atherogenic state typical of T2DM [8]
PMID: 20443773 Nikolopoulos DD, et al
Compounded semaglutide works by mimicking the hormones released by the bodys beta cells to reduce blood sugar levels after meals and help regulate appetite
PlexusDx's precision-wellness approach recognizes that hormonal cycles are a biological variablenot a barrier to treatmentand that personalized context helps optimize safety and tolerability